TABILAUTIDE - AN OVERVIEW

Individuals that are acquiring cyclosporine, tacrolimus or other agents to circumvent graft-compared to-host disease article bone marrow transplant usually are not suitable for this trialExperimental: Dose expansion_sub-population 2_lower dose of niraparib MTDs and/or candidate RP2Ds for elimusertib applied together with niraparib in a reduced fast